CatalystWireBeta

Sale of shares from treasury

In brief · summary, not quotable

Eagle Eye reissued 330,976 treasury shares to new institutional investor at 445p per share.

  • Shares reissued 330,976
  • Issue price 445 pence per share
  • Total ordinary shares in issue 30,222,736
Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your EYE notes

Eagle Eye, a leading provider of applied AI for marketing, enabling personalised, real-time engagement at scale, announces that a total of 330,976 existing ordinary shares of 1p each in the Company ("Ordinary Shares") that were held in treasury ("Treasury Shares") have been reissued and sold to a new institutional investor, at a price of 445 pence per Ordinary Share, to satisfy investor demand. These shares will rank pari passu with the existing Ordinary Shares in issue.

The Board of Eagle Eye agreed to reissue its Treasury Shares to the new institutional investor to support further diversification of the share register, as it understands that while the new institutional investor has acquired Eagle Eye shares in the market, the demand was not able to be fully satisfied from the sale of Ordinary Shares from existing shareholders.

The investment supports the Group's ability to invest as planned, in US sales and AI data science capability, following the Company's recent strong new business performance and increasing commercial momentum, as described in the Interim Results announced in March 2026.

Following the transfer from treasury of the 330,976 Ordinary Shares, the total number of Ordinary shares in issue as at the date of this notice is 30,222,736 with each share carrying the right to one vote. There are no shares held in Treasury. The total number of voting rights in the Company is, therefore, 30,222,736.

The above figure of 30,222,736 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure Guidance and Transparency Rules.

The Board of Eagle Eye is committed to a disciplined approach to capital allocation. Its primary objective is to maximise long-term shareholder value by balancing investment in organic growth, strategic M&A and the return of surplus capital to shareholders. Following the completion of the share buyback programme on 6 March 2026, and as stated at the time, the Board continues to keep its capital allocation priorities under review. In periods of significant excess cash, or where the Board perceives a material undervaluation of the Company's shares, it will utilise buyback programmes to return capital to shareholders.

Web - www.eagleeye.com

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note